News: Tour de Cure

SAiGENCI researchers given a funding boost

Researchers from the South Australian immunoGENomics Cancer Institute (SAiGENCI), based at the University of Adelaide, have been awarded funding to further their work in prostate and pancreatic cancers.

[Read more about SAiGENCI researchers given a funding boost]